Comparison of Cis and Trans Tat gene expression in HIV LTR-based amplifier vectors

BioTechniques

Volumn 33, Issue 5, 2002, Pages 1146-1151

  Zhang, Tong ^a   Tsang, Tom C ^a   Harris, David T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; VIRUSES;

GENE THERAPY;

GENES;

CIS ACTING ELEMENT; INTERLEUKIN 2; TRANS ACTING FACTOR; TRANSACTIVATOR PROTEIN; (3 DIMYRISTYLOXYPROPYL)(DIMETHYL)(HYDROXYETHYL)AMMONIUM; (3-DIMYRISTYLOXYPROPYL)(DIMETHYL)(HYDROXYETHYL)AMMONIUM; HYBRID PROTEIN; LIPID; QUATERNARY AMMONIUM DERIVATIVE; SYNTHETIC DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; LONG TERMINAL REPEAT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PROTEIN DETERMINATION; REPORTER GENE; TRANSACTIVATION; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; EXPERIMENTAL MELANOMA; FIBROBLAST; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 2; LEUKEMIA CELL LINE; MOUSE; PATHOLOGY; PROMOTER REGION; REGULATOR GENE;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; VECTORS;

ANIMALS; CYTOMEGALOVIRUS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; GENE THERAPY; GENES, REPORTER; GENES, SYNTHETIC; GENES, TAT; GENETIC VECTORS; HIV LONG TERMINAL REPEAT; HIV-2; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LIPIDS; MELANOMA, EXPERIMENTAL; MICE; PROMOTER REGIONS (GENETICS); QUATERNARY AMMONIUM COMPOUNDS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0036840735     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/02335dd09     Document Type: Article

References (21)

1. Arya, S.K., C. Guo, S.F. Josephs, and F. Wong-Staal. 1985. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69-73.
2. Chesnoy, S. and L. Huang. 2000. Structure and function of lipid-DNA complexes for gene delivery. Annu. Rev. Biophys. Biomol. Struct. 29:27-47.
3. Escriou, V., C. Ciolina, A. Helbling-Leclerc, P. Wils, and D. Scherman. 1998. Cationic lipid-mediated gene transfer: Analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol. Toxicol. 14:95-104.
4. Felgner, P.L. 1996. Improvements in cationic liposomes for in vivo gene transfer. Hum. Gene Ther. 7:1791-1793.
5. Jeang, K.T., H. Xiao, and E.A. Rich. 1999. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274:28837-28840.
6. Kwak, Y.T., D. Ivanov, J. Guo, E. Nee, and R.B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J. Mol. Biol. 288:57-69.
7. Li, S. and L. Huang. 1997. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4:891-900.
8. Li, S. and L. Huang. 2000. Nonviral gene therapy: Promises and challenges. Gene Ther. 7:31-34.
9. Liang, X., J. Hartikka, L. Sukhu, M. Manthorpe, and P. Hobart. 1996. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3:350-356.
10. Muesing, M.A., D.H. Smith, and D.J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
11. Nabel, G.J. 1999. Development of optimized vectors for gene therapy. Proc. Natl. Acad. Sci. USA 96:324-326.
12. Proudfoot, N.J. 1986. Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322:562-565.
13. Rigg, R.J., J.S. Dando, S. Escaich, I. Plavec, and E. Bohnlein. 1995. Detection of intracellular HIV-1 Rev protein by flow cytometry. J. Immunol. Methods 188:187-195.
14. Soriano, P., G. Friedrich, and P. Lawinger. 1991. Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 65:2314-2319.
15. Tsang, T.C., J.L. Brailey, F. H. Vasanwala, R.S. Wu, F. Liu, P.R. Clark, L. MeadeTollin, L. Luznick, et al. 2000. Construction of new amplifier expression vectors for high levels of IL-2 gene expression. Int. J. Mol. Med. 5:295-300.
16. Tsang, T.C., D.T. Harris, E.T. Akporiaye, R.S. Chu, J. Brailey, F. Liu, F.H. Vasanwala, S.F. Schluter, et al. 1997. Mammalian expression vector with two multiple cloning sites for expression of two foreign genes. BioTechniques 22:68.
17. Verma, I.M. and N. Somia. 1997. Gene therapy-promises, problems, and prospects. Nature 389:239-242.
18. Wheeler, C.J., P.L. Feigner, Y.J. Tsai, J. Marshall, L. Sukhu, S.G. Doh, J. Hartikka, J. Nietupski, et al. 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93:11454-11459.
19. Xu, Z.L., H. Mizuguchi, A. Ishii-Watabe, E. Uchida, T. Mayumi, and T. Hayakawa. 2001. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272:149-156.
20. Yew, N.S., D.M. Wysokenski, K.X. Wang, R.J. Ziegler, J. Marshall, D. McNeilly, M. Cherry, W. Osburn, et al. 1997. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum. Gene Ther. 8:575-584.
21. Zabner, J., A.J. Fasbender, T. Moninger, K.A. Poellinger, and M.J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:18997-19007.